- Home
- LTRY vs NLSP Comparison
LTRY vs NLSP Comparison
Compare LTRY & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRY
- NLSP
- Stock Information
- Founded
- LTRY 2015
- NLSP 2015
- Country
- LTRY United States
- NLSP Switzerland
- Employees
- LTRY N/A
- NLSP N/A
- Industry
- LTRY Computer Software: Prepackaged Software
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- LTRY Technology
- NLSP Health Care
- Exchange
- LTRY Nasdaq
- NLSP Nasdaq
- Market Cap
- LTRY N/A
- NLSP 243.8M
- IPO Year
- LTRY N/A
- NLSP 2021
- Fundamental
- Price
- LTRY $0.49
- NLSP $4.96
- Analyst Decision
- LTRY
- NLSP
- Analyst Count
- LTRY 0
- NLSP 0
- Target Price
- LTRY N/A
- NLSP N/A
- AVG Volume (30 Days)
- LTRY 52.0K
- NLSP 34.6K
- Earning Date
- LTRY 11-29-2024
- NLSP 11-01-2024
- Dividend Yield
- LTRY N/A
- NLSP N/A
- EPS Growth
- LTRY N/A
- NLSP N/A
- EPS
- LTRY N/A
- NLSP N/A
- Revenue
- LTRY $5,723,382.00
- NLSP N/A
- Revenue This Year
- LTRY N/A
- NLSP N/A
- Revenue Next Year
- LTRY N/A
- NLSP N/A
- P/E Ratio
- LTRY N/A
- NLSP N/A
- Revenue Growth
- LTRY 125.44
- NLSP N/A
- 52 Week Low
- LTRY $0.50
- NLSP $4.08
- 52 Week High
- LTRY $7.01
- NLSP $29.68
- Technical
- Relative Strength Index (RSI)
- LTRY 34.24
- NLSP 46.37
- Support Level
- LTRY $0.51
- NLSP $4.52
- Resistance Level
- LTRY $0.57
- NLSP $5.64
- Average True Range (ATR)
- LTRY 0.03
- NLSP 0.48
- MACD
- LTRY 0.01
- NLSP 0.07
- Stochastic Oscillator
- LTRY 0.00
- NLSP 55.44
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.